Valuation Getinge AB Deutsche Boerse AG
Stocks
GTN
SE0000202624
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
10:03:08 13/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.58 EUR | -0.40% |
|
+4.20% | +13.10% |
| 10-13 | Espiria Sweden Small Cap fell 2.2 percent in September, Hansa Biopharma and Volvo Cars weighed | FW |
| 10-13 | Getinge receives FDA approval for new catheter, US launch at end of year | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 69,264 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 16.22% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 77,469 | 75,286 | 72,794 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 11.57% | -2.82% | -3.31% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 21.9x | 19.5x | 17.2x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2.16x | 2.02x | 1.88x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.6x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.96x | 1.85x | 1.76x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.19x | 2.01x | 1.85x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.8x | 9.71x | 8.67x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 15.3x | 13.5x | 11.9x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.6x | 18.1x | 15.7x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.37% | 5.54% | 6.38% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.186 | 5.652 | 6.044 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.04% | 2.22% | 2.38% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.61 | 13.07 | 14.75 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.7% | 43.3% | 41% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,354 | 37,541 | 39,399 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,185 | 7,753 | 8,401 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,054 | 5,579 | 6,125 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,181 | 3,591 | 4,030 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,206 | 6,022 | 3,530 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 254.30 | 254.30 | 254.30 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 28/01/22 | 01/02/23 | 01/02/24 | 28/01/25 | 27/01/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.81x | 3.99x | 15.41x | 2.52% | 176B | |
| 19.66x | 3.56x | 12.74x | 3.06% | 118B | |
| 22x | 4.32x | 15.07x | 1.27% | 108B | |
| 25.99x | 2.56x | 10.26x | 2.76% | 75.34B | |
| 17.8x | 0.21x | 12.98x | 0.73% | 62.03B | |
| 30.51x | 7.58x | 19.51x | 1.31% | 52.8B | |
| 36.4x | 3.49x | 11.96x | 2.08% | 51.45B | |
| 35.48x | 8.82x | 24.71x | -.--% | 41.28B | |
| 48.26x | 1.32x | 12.25x | 0.2% | 31.37B | |
| Average | 29.55x | 3.98x | 14.99x | 1.55% | 79.61B | |
| Weighted average by Cap. | 27.18x | 3.88x | 14.62x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GTN Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
